POD1UM-303/INTERAACT2 subgroup analyses and impact of delayed retifanlimab treatment on outcomes in patients with squamous cell carcinoma of the anal canal (SCAC).
Year: 2025
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Marwan Fakih, Rebecca Muirhead, Aaron J. Scott, Mohit Narang, Allen Lee Cohn, Marcia ROXANA Cruz-Correa, Mukul Gupta, Sharadah Essapen, Duncan C. Gilbert, Toshihiro Kudo, David Kar Wah Lau, Maria Carmen Riesco Martinez, M. Giulia Zampino, Christelle De La Fouchardiere, Jill Harrison, Mark M. Jones, Chuan Tian, Atsuo Takashima, Jaume Capdevila, Sheela Rao
Institutions: City Of Hope National Medical Center, Oxford University Hospitals NHS Trust, University of Arizona Cancer Center, Rocky Mountain Cancer Centers, University of Puerto Rico, Medical Sciences Campus, University of Puerto Rico System, Sansum Medical Clinic, Royal Surrey County Hospital, University College London, Osaka International Cancer Institute, Monash Health, Hospital Universitario 12 De Octubre, European Institute of Oncology, Institut Paoli-Calmettes, Incyte (United States), National Cancer Center Hospital, Vall d'Hebron Hospital Universitari, Vall d'Hebron Institute of Oncology, Royal Marsden NHS Foundation Trust
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4410805065